Mary Pinder-Schenck is an Oncology physician affiliated with Merck & Co.. OpenAlex indexes 21 publications with 2,753 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Magnolia Drive
Tampa, FL 33612
Telephone
813-745-2826Registry record last updated 26 Mar 2014.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
Cancer Immunology Immunotherapy
2018 - Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial
International Journal of Radiation Oncology*Biology*Physics
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Lubiniecki, MD
Merck & Co.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”